Appraisal of the cardiovascular risks of azithromycin: an observational analysis.

about

Appraisal of the cardiovascular risks of azithromycin: an observational analysis.

Item

http://www.wikidata.org/entity/Q50272937

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Appraisal of the cardiovascular risks of azithromycin: an observational analysis.

@en

Appraisal of the cardiovascular risks of azithromycin: an observational analysis.

@nl

type

Item

label

Appraisal of the cardiovascular risks of azithromycin: an observational analysis.

@en

Appraisal of the cardiovascular risks of azithromycin: an observational analysis.

@nl

prefLabel

Appraisal of the cardiovascular risks of azithromycin: an observational analysis.

@en

Appraisal of the cardiovascular risks of azithromycin: an observational analysis.

@nl

P1476

Appraisal of the cardiovascular risks of azithromycin: an observational analysis.

@en

P2093

James W Hardin

http://www.w3.org/2001/XMLSchema#string

Joseph Magagnoli

http://www.w3.org/2001/XMLSchema#string

S Scott Sutton

http://www.w3.org/2001/XMLSchema#string

Stephanie Hyche

http://www.w3.org/2001/XMLSchema#string

P2860

Azithromycin and the risk of cardiovascular death

Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia.

Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research.

Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.

Use of azithromycin and death from cardiovascular causes.

Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food and Drug Administration Adverse Event Reporting System.

Cardiac risks associated with antibiotics: azithromycin and levofloxacin

Azithromycin and Risk of Cardiovascular Death: A Meta-Analytic Review of Observational Studies.

Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death.

Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.

P304

509-517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/CER-2016-0080

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28960092

http://www.w3.org/2001/XMLSchema#string

P921

azithromycin